|
|
Long-term efficacy and safety of Oulongma Drops in children with nasal-sinusitis |
MENG Xiangtao1 YANG Xiao2 |
1.Department of ENT, Zhuozhou City Hospital, Hebei Province, Baoding 072750, China;
2.Department of Paediatrics, Zhuozhou City Hospital, Hebei Province, Baoding 072750, China |
|
|
Abstract Objective To explore the long-term efficacy of Oulongma Drops in children with nasal sinusitis and to analyze the safety of treatment. Methods A total of 300 cases of nasal-sinusitis were enrolled in Zhuozhou City Hospital from January 2016 to January 2017. They were divided into 100 cases of group A, B and C according to the random number table, patients of the group A and group B were treated with Oulongma Drops, 1-6-year-old children of group A with starting dose of 4 mL/time, after 5 d adjusted to 2 mL/time, >6-12 years old children 6 mL/time, after 5 d to 3 mL/time, 1-6 years old children of group B were given the dose of 2 mL/time, >6-12 years old mL/time, group C was given Mu Shu Tan syrup treatment, 1-6 children 2.5 mL/time, >6-12 years old 5 mL/time. The clinical efficacy of the two groups in 1 and 3 months after treatment were observed, and the recurrence rate was analyzed after 8 months follow-up. The nasal, mucosal hyperemia, sleep disorders, runny nose scores were assessed by the nasal sinus outcome test-20 (SNOT-20) scale and the adverse events were recorded. Results The total effective rates of group A and group B were 90.0% and 89.0% respectively, which were higher than that of group C (72.0%), the difference was statistically significant (P < 0.05). The total effective rate of group A, B and C after 3 months was 88.0%, 86.0%, 61.0%, and the recurrence rate was 2.0%, 3.0% and 11.0% respectively, the total effective rate of group C was lower than that of A and B group, the recurrence rate was higher than that of group A and B, the differences were statistically significant (P < 0.05). The scores of nasal congestion and mucosal congestion were lower in group A and group B than those in group C (P < 0.05). The incidence of adverse reactions in group B was 2.0%, which was lower than that in group A and group C (9.0%, 9.0%), the difference was statistically significant (P < 0.05). Conclusion Compared with the Mu Shu Tan syrup, the Oulongma Drops can further improve the nasal sinusitis in children with symptoms, curative effect is distinct, the small dosage of medicine not only can obtain ideal therapeutic effect, but also with low incidence of adverse reactions, worthy of clinical promotion.
|
|
|
|
|
[1] 黄小燕,冯琨,刘丹,等.pendrin在慢性鼻-鼻窦炎黏膜中的表达及其与黏蛋白5AC表达的相关性[J].中华医学杂志,2015,95(14):1078-1082.
[2] 刘小凤,丁跃明.慢性鼻-鼻窦炎伴鼻息肉患者上颌窦微生物感染的类型对鼻内镜手术近期疗效的影响[J].广东医学,2015,36(2):227-229.
[3] Saibene AM,Vassena C,Pipolo C,et al. Odontogenic and rhinogenic chronic sinusitis:a modern microbiological comparison [J]. Int Forum Allergy Rhinol,2016,6(1):41-45.
[4] 许锦,蔡惠惠,刘彬,等.欧龙马滴剂与拉氧头孢相互作用致儿童双硫仑样反应1例[J].中国药师,2017,20(11):2035-2036.
[5] 中华耳鼻咽喉头颈外科杂志编委会.慢性鼻-鼻窦炎诊断和治疗指南(2008年,南昌)[J].中华耳鼻咽喉头颈外科杂志,2009,44(1):6-7.
[6] 廖亚玲.慢性鼻炎鼻窦炎[M].南京:江苏科学技术出版社,2011.
[7] 左可军,方积乾,Piccirillo JF,等.鼻腔鼻窦结局测试-20(SNOT-20)量表中文版的研制[J].中华耳鼻咽喉头颈外科杂志,2008,43(10):751-756.
[8] 李玥,汪银凤.嗜酸粒细胞分类伴息肉型慢性鼻-鼻窦炎的临界值观察[J].安徽医科大学学报,2017,52(8):1210-1214.
[9] 刘静,唐艺芬,朱佳.鼻渊舒口服液合西医常规治疗儿童慢性鼻窦炎53例临床观察[J].中医药导报,2016,22(5):89-91.
[10] Bachert C. Innovative therapeutic targets in chronic sinusitis with nasal polyps [J]. Braz J Otorhinolaryngol,2016, 82(3):251-252.
[11] 林琳,周霓,陈子松.真菌性鼻-鼻窦炎189例临床分析[J].临床耳鼻咽喉头颈外科杂志,2015,29(23):2064-2066.
[12] 史丽,赵莉.慢性鼻-鼻窦炎黏膜炎症机制研究及临床诊断概况[J].临床耳鼻咽喉头颈外科杂志,2016,30(3):183-186.
[13] 李良波,龚成,廖勇,等.清窦灵合剂治疗儿童慢性鼻-鼻窦炎临床研究[J].南京中医药大学学报,2016,32(1):29-31.
[14] 沈莹,罗蜜,张建斌,等.欧龙马滴剂联合鼻内镜治疗放射性鼻窦炎疗效观察[J].中国药师,2016,19(12):2275-2277.
[15] 庄丽萍,黄阿勤,郭育华,等.放射性鼻窦炎患者接受鼻内镜下负压清理联合欧龙马滴剂冲洗的损伤程度及炎症程度评价[J].海南医学院学报,2016,22(24):3094-3096.
[16] 谷李欣,丁小军,李亚薇,等.欧龙马滴剂联合阿奇霉素治疗儿童慢性鼻窦炎的疗效观察[J].现代药物与临床,2015,30(7):833-836.
[17] 林文彪,全超坤,张龙城.鼻内镜下鼻腔负压清理联合欧龙马滴剂雾化冲洗治疗放射性鼻窦炎[J].临床耳鼻咽喉头颈外科杂志,2015,29(23):2019-2022.
[18] Singh BS. Comment on the Effect of Nasal Septal Deviation on Frontal and Maxillary Sinus Volumes and Development of Sinusitis [J]. J Craniofac Surg,2016,27(2):533-533.
[19 Bj?覬rndal L,Amaloo C,Markvart M,et al. Maxillary Sinus Impaction of a Core Carrier Causing Sustained Apical Periodontitis,Sinusitis,and Nasal Stenosis:A 3-year Follow-up [J]. J Endod,2016,42(12):1851-1858.
[20] 陈丹,陈璐,Beule AG,等.慢性鼻-鼻窦炎临床诊治进展[J].重庆医学,2015,44(23):3286-3288. |
|
|
|